ProCE Banner Activity

Ocular Toxicity Associated With Antibody–Drug Conjugates in Gynecologic Cancers: An HCP Resource

PDF
Download this resource with key information on monitoring, mitigating, and recognizing ocular adverse events associated with antibody–drug conjugates used to treat gynecologic cancers.

Released: July 27, 2022

Expiration: July 26, 2023

No longer available for credit.

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Genmab

Seagen